Innoveren Scientific (IVRN) Financial Statements
Innoveren Scientific Financial Overview
Innoveren Scientific's market cap is currently $3.20K. The company's EPS TTM is ―; its P/E ratio is ―; Innoveren Scientific has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 335.86K | $ 906.81K | $ 1.38M | $ 6.29M | $ 5.52M |
| Operating Income | $ -5.11M | $ -5.29M | $ -7.09M | $ -15.05M | $ -3.60M |
| EBITDA | $ -9.92M | $ -4.61M | $ -4.92M | $ -28.52M | $ -4.11M |
| Net Income | $ -10.30M | $ -4.80M | $ -6.46M | $ -29.81M | $ -4.39M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 137.36K | $ 321.40K | $ 2.20M | $ 3.27M | $ 454.90K |
| Total Debt | $ 3.92M | $ 3.62M | $ 1.17M | $ 1.26M | $ 5.00M |
| Net Debt | $ 3.92M | $ 3.52M | $ -467.88K | $ -165.19K | $ 4.93M |
| Total Liabilities | $ 9.49M | $ 4.98M | $ 3.25M | $ 12.73M | $ 6.49M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -1.91M | $ -4.82M | $ -7.26M | $ -12.31M | $ -3.57M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD